Follow-up of 5-year Old Children Born After PGD

January 13, 2017 updated by: Christine de Die- Smulders, Maastricht University Medical Center

Long-term Safety of Preimplantation Genetic Diagnosis. Follow-up of 5-year Old Children Born After PGD.

Since 1995, preimplantation genetic diagnosis (PGD) has been performed in The Netherlands for couples at high risk for transmitting severe or lethal genetic conditions or who have experienced multiple miscarriages due to chromosomal translocations. Approximately 260 children have been born after PGD in The Netherlands. Follow-up data on children born after PGD are scarce. Long-term studies on PGD children have not been conducted in The Netherlands. Results of studies in other countries on 2-year old PGD children are reassuring. These children and their parents have normal scores on relevant parameters such as general health, cognitive and socioemotional development, parent-child interaction and parental stress. Studies of good methodological quality of older children have not yet been published.

Objective: Long-term follow-up of children who have been born after PGD in The Netherlands. The primary aim is to assess the safety of PGD with regard to the health and development of the children.

Study design: A cohort study. Study population: 5- and 8 year old children born after PGD in The Netherlands for various indications and their parents. Control groups consist of 5 and 8-year old naturally conceived (NC) children of parents who have considered PGD treatment and 5 and 8-year old children born after in vitro fertilisation/intracytoplasmatic sperm injection (IVF/ICSI), and the parents of the two latter groups of children.

Study Overview

Status

Unknown

Detailed Description

Parents are asked to fill out questionnaires on their own and their child's medical history. A physical examination of the children will be performed, a swab for collection of buccal cells for (future) DNA methylation analysis will be taken and their cognitive and socioemotional development will be assessed. In the 8 years old children cardiovascular status will be evaluated.

Main study parameters: general health, cognitive and socioemotional development, parent-child interaction and parental stress.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:

The study procedure consists of filling out questionnaires by parents and a one-time visit to the hospital. No invasive interventions will be performed, except 1 tube of blood in the 8 year old group. The risks associated with the study procedure are very small. The results provide more information about the risks of PGD to prospective parents who are considering PGD and to healthcare providers involved in PGD treatment.

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Utrecht, Netherlands
    • Limburg
      • Maastricht, Limburg, Netherlands, 6202AZ
        • Recruiting
        • Maastricht University Hospital
        • Contact:
          • Christine de Die-Smulders, MD PhD
          • Phone Number: +31 43 3875897
          • Email: c.dedie@mumc.nl

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 5 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

5 years old children born after preimplantation genetic diagnosis

Description

Inclusion criteria:

PGD children

  • 5-year old singleton PGD children with Caucasian parents
  • Children must have the Dutch language as their mother tongue for participation in the intelligence quotient (IQ) test. Children that do not have Dutch as their mother tongue will be excluded from the IQ test, but can take part in the rest of the procedure

Naturally conceived (NC) children

  • 5-year old singleton NC children with Caucasian parents, matched with PGD children on age and sex
  • Parents must have attended the PGD clinic in Maastricht for an informative consultation
  • Parents must have become pregnant without any assisted reproductive technique
  • Children must have the Dutch language as their mother tongue

IVF/ICSI children

  • 5-year old singleton IVF/ICSI children with Caucasian parents, matched with PGD children on age and sex
  • Children must have the Dutch language as their mother tongue

Exclusion criteria:

PGD children

  • Twins or triplets
  • Parents of non-Caucasian descent
  • Children with known chromosomal abnormalities (e.g. trisomy 21) or gene disorders with childhood expression of symptoms

NC children

  • Twins or triplets
  • Parents of non-Caucasian descent
  • Children with known chromosomal abnormalities or gene disorders with childhood expression of symptoms

IVF/ICSI children

  • Twins or triplets
  • Parents of non-Caucasian descent
  • Children with known chromosomal abnormalities or gene disorders with childhood expression of symptoms

    8 years old group Former participants of the study in 5 year old children

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical health of 5 years old children born after preimplantation genetic diagnosis
Time Frame: 5 years
Physical health of 5 and 8 years old children born after PGD will be assessed by physical examination and measurement of height, weight and compared with children born after IVF/ICSI and naturally conceived children.
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological health of 5 and 8 years old children born after preimplantation genetic diagnosis
Time Frame: 5 years
Psychological health will be assesses by neuropsychological testing, and questionaires
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christine de Die-Smulders, MD PhD, Maastricht University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Anticipated)

December 1, 2018

Study Completion (Anticipated)

December 1, 2018

Study Registration Dates

First Submitted

May 20, 2014

First Submitted That Met QC Criteria

May 28, 2014

First Posted (Estimate)

May 29, 2014

Study Record Updates

Last Update Posted (Estimate)

January 16, 2017

Last Update Submitted That Met QC Criteria

January 13, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 13-2010

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preimplantation Genetic Diagnosis

Subscribe